ID

17928

Descripción

A Study to Evaluate Tarceva in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC); ODM derived from: https://clinicaltrials.gov/show/NCT00091663

Link

https://clinicaltrials.gov/show/NCT00091663

Palabras clave

Versiones (1)
  1. 10/10/16 10/10/16 -
Subido en

10 de octubre de 2016

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Lung Cancer NCT00091663

Inglés

Eligibility Lung Cancer NCT00091663

1 formularios  
Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
written (signed) informed consent(s)
Descripción

Informed Consent

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0021430
inoperable and incurable, locally advanced, recurrent or metastatic nsclc
Descripción

Non-Small Cell Lung Carcinoma Inoperable incurable | Non-Small Cell Lung Carcinoma Advanced Locally | Non-small cell lung cancer recurrent | Non-small cell lung cancer metastatic

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0007131
UMLS CUI [1,2]
C0205187
UMLS CUI [1,3]
C0175969
UMLS CUI [2,1]
C0007131
UMLS CUI [2,2]
C0205179
UMLS CUI [2,3]
C1517927
UMLS CUI [3]
C0278517
UMLS CUI [4]
C0278987
relapse following standard chemotherapy (combination chemotherapy such as two-drug combination chemotherapy, or a single-agent chemotherapy agent for elderly or poor performance status patients)
Descripción

Chemotherapy | Relapse | Combination Chemotherapy | Combination Chemotherapy Pharmaceutical Preparations Two | Chemotherapy, single agent Patients Elderly | Chemotherapy, single agent Patients poor performance status

Tipo de datos

boolean

Alias
UMLS CUI [1]
C3665472
UMLS CUI [2]
C0035020
UMLS CUI [3]
C1521750
UMLS CUI [4,1]
C1521750
UMLS CUI [4,2]
C0013227
UMLS CUI [4,3]
C0205448
UMLS CUI [5,1]
C3846440
UMLS CUI [5,2]
C0030705
UMLS CUI [5,3]
C0001792
UMLS CUI [6,1]
C3846440
UMLS CUI [6,2]
C0030705
UMLS CUI [6,3]
C1831741
age >=18 years
Descripción

Age

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0001779
ecog performance status of 0 to 3
Descripción

ECOG performance status

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1520224
recovered from the toxic effects of prior therapy
Descripción

Toxic effect Due to Prior Therapy | Patient Recovered

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0600688
UMLS CUI [1,2]
C0678226
UMLS CUI [1,3]
C1514463
UMLS CUI [2,1]
C0030705
UMLS CUI [2,2]
C0521108
able to comply with study and follow-up procedures
Descripción

Protocol Compliance

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0525058
able to take oral medication
Descripción

Able to take medication Oral

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C4075001
UMLS CUI [1,2]
C1527415
use of an effective means of contraception (for patients with reproductive potential)
Descripción

Fertility Contraceptive methods

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0015895
UMLS CUI [1,2]
C0700589
granulocyte count >=1.0 x 10^9/l
Descripción

Granulocyte count

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0857490
platelet count >=75 x 10^9/l
Descripción

Platelet Count measurement

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0032181
serum bilirubin <1.5 x upper limit of normal (uln)
Descripción

Serum total bilirubin measurement

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1278039
sgot (ast) <2 x uln unless elevation is clearly due to liver metastases; then sgot (ast) must be <5 x uln
Descripción

Aspartate aminotransferase measurement | Aspartate aminotransferase increased Due to Secondary malignant neoplasm of liver

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0201899
UMLS CUI [2,1]
C0151904
UMLS CUI [2,2]
C0678226
UMLS CUI [2,3]
C0494165
serum creatinine <=1.5 mg/dl
Descripción

Creatinine measurement, serum

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0201976
Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
any unstable systemic disease (including active infection, unstable angina, congestive heart failure, myocardial infarction within the last 6 months, hepatic, renal, or metabolic disease)
Descripción

Systemic disease Unstable | Communicable Diseases | Angina, Unstable | Congestive heart failure | Myocardial Infarction | Liver diseases | Kidney Diseases | Metabolic Diseases

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0442893
UMLS CUI [1,2]
C0443343
UMLS CUI [2]
C0009450
UMLS CUI [3]
C0002965
UMLS CUI [4]
C0018802
UMLS CUI [5]
C0027051
UMLS CUI [6]
C0023895
UMLS CUI [7]
C0022658
UMLS CUI [8]
C0025517
prior therapy with any systemic her1/egfr small molecule inhibitor, including gefitinib (iressa), erlotinib (tarceva), or other investigational agents in this class
Descripción

HER1 Antagonists Small Molecule Systemic | gefitinib | Iressa | erlotinib | Tarceva | Investigational New Drugs

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C2916831
UMLS CUI [1,2]
C1328819
UMLS CUI [1,3]
C0205373
UMLS CUI [2]
C1122962
UMLS CUI [3]
C0919281
UMLS CUI [4]
C1135135
UMLS CUI [5]
C1135136
UMLS CUI [6]
C0013230
history of another malignancy in the past 2 years unless the malignancy has been adequately treated and is associated with a 5-year anticipated survival of >=90%
Descripción

Malignant Neoplasm | Malignant Neoplasm Treated Adequate | Continuance of life Anticipated

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0006826
UMLS CUI [2,1]
C0006826
UMLS CUI [2,2]
C1522326
UMLS CUI [2,3]
C0205411
UMLS CUI [3,1]
C0038952
UMLS CUI [3,2]
C3840775
known central nervous system (cns) metastases that have not yet been definitively treated with surgery and/or radiation or that are symptomatic or unstable
Descripción

CNS metastases untreated | Operative Surgical Procedures | Therapeutic radiology procedure | CNS metastases Symptomatic | CNS metastases Unstable

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0686377
UMLS CUI [1,2]
C0332155
UMLS CUI [2]
C0543467
UMLS CUI [3]
C1522449
UMLS CUI [4,1]
C0686377
UMLS CUI [4,2]
C0231220
UMLS CUI [5,1]
C0686377
UMLS CUI [5,2]
C0443343
nursing mothers or pregnant females
Descripción

Breast Feeding | Pregnancy

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0006147
UMLS CUI [2]
C0032961
Volver a la parte superior de la página

Similar models

Eligibility Lung Cancer NCT00091663

1 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
Informed Consent
Item
written (signed) informed consent(s)
boolean
C0021430 (UMLS CUI [1])
Non-Small Cell Lung Carcinoma Inoperable incurable | Non-Small Cell Lung Carcinoma Advanced Locally | Non-small cell lung cancer recurrent | Non-small cell lung cancer metastatic
Item
inoperable and incurable, locally advanced, recurrent or metastatic nsclc
boolean
C0007131 (UMLS CUI [1,1])
C0205187 (UMLS CUI [1,2])
C0175969 (UMLS CUI [1,3])
C0007131 (UMLS CUI [2,1])
C0205179 (UMLS CUI [2,2])
C1517927 (UMLS CUI [2,3])
C0278517 (UMLS CUI [3])
C0278987 (UMLS CUI [4])
Chemotherapy | Relapse | Combination Chemotherapy | Combination Chemotherapy Pharmaceutical Preparations Two | Chemotherapy, single agent Patients Elderly | Chemotherapy, single agent Patients poor performance status
Item
relapse following standard chemotherapy (combination chemotherapy such as two-drug combination chemotherapy, or a single-agent chemotherapy agent for elderly or poor performance status patients)
boolean
C3665472 (UMLS CUI [1])
C0035020 (UMLS CUI [2])
C1521750 (UMLS CUI [3])
C1521750 (UMLS CUI [4,1])
C0013227 (UMLS CUI [4,2])
C0205448 (UMLS CUI [4,3])
C3846440 (UMLS CUI [5,1])
C0030705 (UMLS CUI [5,2])
C0001792 (UMLS CUI [5,3])
C3846440 (UMLS CUI [6,1])
C0030705 (UMLS CUI [6,2])
C1831741 (UMLS CUI [6,3])
Age
Item
age >=18 years
boolean
C0001779 (UMLS CUI [1])
ECOG performance status
Item
ecog performance status of 0 to 3
boolean
C1520224 (UMLS CUI [1])
Toxic effect Due to Prior Therapy | Patient Recovered
Item
recovered from the toxic effects of prior therapy
boolean
C0600688 (UMLS CUI [1,1])
C0678226 (UMLS CUI [1,2])
C1514463 (UMLS CUI [1,3])
C0030705 (UMLS CUI [2,1])
C0521108 (UMLS CUI [2,2])
Protocol Compliance
Item
able to comply with study and follow-up procedures
boolean
C0525058 (UMLS CUI [1])
Able to take medication Oral
Item
able to take oral medication
boolean
C4075001 (UMLS CUI [1,1])
C1527415 (UMLS CUI [1,2])
Fertility Contraceptive methods
Item
use of an effective means of contraception (for patients with reproductive potential)
boolean
C0015895 (UMLS CUI [1,1])
C0700589 (UMLS CUI [1,2])
Granulocyte count
Item
granulocyte count >=1.0 x 10^9/l
boolean
C0857490 (UMLS CUI [1])
Platelet Count measurement
Item
platelet count >=75 x 10^9/l
boolean
C0032181 (UMLS CUI [1])
Serum total bilirubin measurement
Item
serum bilirubin <1.5 x upper limit of normal (uln)
boolean
C1278039 (UMLS CUI [1])
Aspartate aminotransferase measurement | Aspartate aminotransferase increased Due to Secondary malignant neoplasm of liver
Item
sgot (ast) <2 x uln unless elevation is clearly due to liver metastases; then sgot (ast) must be <5 x uln
boolean
C0201899 (UMLS CUI [1])
C0151904 (UMLS CUI [2,1])
C0678226 (UMLS CUI [2,2])
C0494165 (UMLS CUI [2,3])
Creatinine measurement, serum
Item
serum creatinine <=1.5 mg/dl
boolean
C0201976 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Systemic disease Unstable | Communicable Diseases | Angina, Unstable | Congestive heart failure | Myocardial Infarction | Liver diseases | Kidney Diseases | Metabolic Diseases
Item
any unstable systemic disease (including active infection, unstable angina, congestive heart failure, myocardial infarction within the last 6 months, hepatic, renal, or metabolic disease)
boolean
C0442893 (UMLS CUI [1,1])
C0443343 (UMLS CUI [1,2])
C0009450 (UMLS CUI [2])
C0002965 (UMLS CUI [3])
C0018802 (UMLS CUI [4])
C0027051 (UMLS CUI [5])
C0023895 (UMLS CUI [6])
C0022658 (UMLS CUI [7])
C0025517 (UMLS CUI [8])
HER1 Antagonists Small Molecule Systemic | gefitinib | Iressa | erlotinib | Tarceva | Investigational New Drugs
Item
prior therapy with any systemic her1/egfr small molecule inhibitor, including gefitinib (iressa), erlotinib (tarceva), or other investigational agents in this class
boolean
C2916831 (UMLS CUI [1,1])
C1328819 (UMLS CUI [1,2])
C0205373 (UMLS CUI [1,3])
C1122962 (UMLS CUI [2])
C0919281 (UMLS CUI [3])
C1135135 (UMLS CUI [4])
C1135136 (UMLS CUI [5])
C0013230 (UMLS CUI [6])
Malignant Neoplasm | Malignant Neoplasm Treated Adequate | Continuance of life Anticipated
Item
history of another malignancy in the past 2 years unless the malignancy has been adequately treated and is associated with a 5-year anticipated survival of >=90%
boolean
C0006826 (UMLS CUI [1])
C0006826 (UMLS CUI [2,1])
C1522326 (UMLS CUI [2,2])
C0205411 (UMLS CUI [2,3])
C0038952 (UMLS CUI [3,1])
C3840775 (UMLS CUI [3,2])
CNS metastases untreated | Operative Surgical Procedures | Therapeutic radiology procedure | CNS metastases Symptomatic | CNS metastases Unstable
Item
known central nervous system (cns) metastases that have not yet been definitively treated with surgery and/or radiation or that are symptomatic or unstable
boolean
C0686377 (UMLS CUI [1,1])
C0332155 (UMLS CUI [1,2])
C0543467 (UMLS CUI [2])
C1522449 (UMLS CUI [3])
C0686377 (UMLS CUI [4,1])
C0231220 (UMLS CUI [4,2])
C0686377 (UMLS CUI [5,1])
C0443343 (UMLS CUI [5,2])
Breast Feeding | Pregnancy
Item
nursing mothers or pregnant females
boolean
C0006147 (UMLS CUI [1])
C0032961 (UMLS CUI [2])
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial